Serotonergic neurotoxic metabolites of ecstasy identified in rat brain

被引:99
作者
Jones, DC
Duvauchelle, C
Ikegami, A
Olsen, CM
Lau, SS
de la Torre, R
Monks, TJ
机构
[1] Univ Arizona, Hlth Sci Ctr, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA
[2] Univ Texas, Coll Pharm, Div Pharmacol & Toxicol, Austin, TX 78712 USA
[3] Inst Municipal Invest Med, Pharmacol Res Unit, E-08003 Barcelona, Spain
关键词
D O I
10.1124/jpet.104.077628
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The selective serotonergic neurotoxicity of 3,4-methylenedioxyamphetamine (MDA) and 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) depends on their systemic metabolism. We have recently shown that inhibition of brain endothelial cell gamma-glutamyl transpeptidase (gamma-GT) potentiates the neurotoxicity of both MDMA and MDA, indicating that metabolites that are substrates for this enzyme contribute to the neurotoxicity. Consistent with this view, glutathione (GSH) and N-acetylcysteine conjugates of alpha-methyl dopamine (alpha-MeDA) are selective neurotoxicants. However, neurotoxic metabolites of MDMA or MDA have yet to be identified in brain. Using in vivo microdialysis coupled to liquid chromatography-tandem mass spectroscopy and a high-performance liquid chromatography-coulometric electrode array system, we now show that GSH and N-acetylcysteine conjugates of N-methyl-alpha-MeDA are present in the striatum of rats administered MDMA by subcutaneous injection. Moreover, inhibition of gamma-GT with acivicin increases the concentration of GSH and N-acetylcysteine conjugates of N-methyl-alpha-MeDA in brain dialysate, and there is a direct correlation between the concentrations of metabolites in dialysate and the extent of neurotoxicity, measured by decreases in serotonin (5-HT) and 5-hydroxyindole acetic (5-HIAA) levels. Importantly, the effects of acivicin are independent of MDMA-induced hyperthermia, since acivicin-mediated potentiation of MDMA neurotoxicity occurs in the context of acivicin-mediated decreases in body temperature. Finally, we have synthesized 5-(N-acetylcystein-S-yl)-N-methyl-alpha-MeDA and established that it is a relatively potent serotonergic neurotoxicant. Together, the data support the contention that MDMA-mediated serotonergic neurotoxicity is mediated by the systemic formation of GSH and N-acetylcysteine conjugates of N-methyl-alpha-MeDA (and alpha-MeDA). The mechanisms by which such metabolites access the brain and produce selective serotonergic neurotoxicity remain to be determined.
引用
收藏
页码:422 / 431
页数:10
相关论文
共 41 条
[1]   Serotonergic neurotoxicity of 3,4-(±) -methylenedioxyamphetamine and 3,4-(±)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of γ-glutamyl transpeptidase [J].
Bai, FJ ;
Jones, DC ;
Lau, SS ;
Monks, TJ .
CHEMICAL RESEARCH IN TOXICOLOGY, 2001, 14 (07) :863-870
[2]   Glutathione and N-acetylcysteine conjugates of α-methyldopamine produce serotonergic neurotoxicity:: Possible role in methylenedioxyamphetamine-mediated neurotoxicity [J].
Bai, FJ ;
Lau, SS ;
Monks, TJ .
CHEMICAL RESEARCH IN TOXICOLOGY, 1999, 12 (12) :1150-1157
[3]   17 beta-Estradiol metabolism by hamster hepatic microsomes: Comparison of catechol estrogen O-methylation with catechol estrogen oxidation and glutathione conjugation [J].
Butterworth, M ;
Lau, SS ;
Monks, TJ .
CHEMICAL RESEARCH IN TOXICOLOGY, 1996, 9 (04) :793-799
[4]   Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR [J].
Colado, MI ;
Granados, R ;
O'Shea, E ;
Esteban, B ;
Green, AR .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (03) :479-484
[5]   Neurotoxicity of MDMA (ecstasy):: the limitations of scaling from animals to humans [J].
de la Torre, R ;
Farré, M .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (10) :505-508
[6]   Human pharmacology of MDMA -: Pharmacokinetics, metabolism, and disposition [J].
de la Torre, R ;
Farré, M ;
Roset, PN ;
Pizarro, N ;
Abanades, S ;
Segura, M ;
Segura, J ;
Camí, J .
THERAPEUTIC DRUG MONITORING, 2004, 26 (02) :137-144
[7]   Effects of cocaine context on NAcc dopamine and behavioral activity after repeated intravenous cocaine administration [J].
Duvauchelle, CL ;
Ikegami, A ;
Asami, S ;
Robens, J ;
Kressin, K ;
Castaneda, E .
BRAIN RESEARCH, 2000, 862 (1-2) :49-58
[8]   LONG-TERM ALTERATION IN THE CENTRAL MONOAMINERGIC SYSTEMS OF THE RAT BY 2,4,5-TRIHYDROXYAMPHETAMINE BUT NOT BY 2-HYDROXY-4,5-METHYLENEDIOXYMETHAMPHETAMINE OR 2-HYDROXY-4,5-METHYLENEDIOXYAMPHETAMINE [J].
ELAYAN, I ;
GIBB, JW ;
HANSON, GR ;
FOLTZ, RL ;
LIM, HK ;
JOHNSON, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 221 (2-3) :281-288
[9]   3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected nenrotoxic dose [J].
Esteban, B ;
O'Shea, E ;
Camarero, J ;
Sanchez, V ;
Green, AR ;
Colado, MI .
PSYCHOPHARMACOLOGY, 2001, 154 (03) :251-260
[10]   An antisense oligonucleotide targeted at MAO-B attenuates rat striatal serotonergic neurotoxicity induced by MDMA [J].
Falk, EM ;
Cook, VJ ;
Nichols, DE ;
Sprague, JE .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2002, 72 (03) :617-622